Ipsen S.A. (IPSEY)
PNK: IPSEY
· Real-Time Price · USD
28.20
0.00 (0.00%)
At close: May 01, 2025, 3:44 PM
0.00% (1D)
| Bid | 27.59 |
| Market Cap | 37.32B |
| Revenue (ttm) | 3.34B |
| Net Income (ttm) | 681.2M |
| EPS (ttm) | 1.21 |
| PE Ratio (ttm) | 23.31 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 29.85 |
| Volume | 239 |
| Avg. Volume (20D) | 6,255 |
| Open | 27.00 |
| Previous Close | 28.20 |
| Day's Range | 27.00 - 28.20 |
| 52-Week Range | 25.11 - 34.06 |
| Beta | 0.40 |
About IPSEY
Ipsen S.A. operates as a biopharmaceutical company worldwide. The company provides drugs in the areas of oncology, neuroscience, gastroenterology, cognitive disorders, and rare diseases. It offers Somatuline for neuroendocrine tumors and acromegaly; Decapeptyl for the treatment of advanced metastatic prostate cancer; Cabometyx for renal cell and second-line hepatocellular carcinoma; Onivyde for second-line metastatic pancreatic cancer; Dysport fo...
Sector Healthcare
IPO Date Aug 3, 2012
Employees 5,358
Stock Exchange PNK
Ticker Symbol IPSEY
Website https://www.ipsen.com
